{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:16:15Z","timestamp":1781075775643,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00415-025-12890-y","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T11:13:34Z","timestamp":1740222814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Seizure freedom and therapy discontinuation in patients with idiopathic generalized epilepsy: retrospective cohort study from a tertiary epilepsy outpatient service"],"prefix":"10.1007","volume":"272","author":[{"given":"Davide G.","family":"Curti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cursi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Lanzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Minicucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna F.","family":"Fanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Agosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5485-0479","authenticated-orcid":false,"given":"Massimo","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,22]]},"reference":[{"key":"12890_CR1","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/epi.13709","volume":"58","author":"IE Scheffer","year":"2017","unstructured":"Scheffer IE, Berkovic S, Capovilla G et al (2017) ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology. Epilepsia 58:512\u2013521. https:\/\/doi.org\/10.1111\/epi.13709","journal-title":"Epilepsia"},{"key":"12890_CR2","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1111\/epi.17236","volume":"63","author":"E Hirsch","year":"2022","unstructured":"Hirsch E, French J, Scheffer IE et al (2022) ILAE definition of the idiopathic generalized epilepsy syndromes: position statement by the ILAE task force on nosology and definitions. Epilepsia 63:1475\u20131499. https:\/\/doi.org\/10.1111\/epi.17236","journal-title":"Epilepsia"},{"key":"12890_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1684\/epd.2020.1192","volume":"22","author":"AD Elmali","year":"2020","unstructured":"Elmali AD, Auvin S, Bast T et al (2020) How to diagnose and classify idiopathic (genetic) generalized epilepsies. Epileptic Disord 22:399\u2013420. https:\/\/doi.org\/10.1684\/epd.2020.1192","journal-title":"Epileptic Disord"},{"key":"12890_CR4","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3988\/jcn.2016.12.2.160","volume":"12","author":"HR Kim","year":"2016","unstructured":"Kim HR, Kim G-H, Eun S-H et al (2016) Therapeutic outcomes and prognostic factors in childhood absence epilepsy. J Clin Neurol 12:160. https:\/\/doi.org\/10.3988\/jcn.2016.12.2.160","journal-title":"J Clin Neurol"},{"key":"12890_CR5","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s00415-004-0521-1","volume":"251","author":"E Trinka","year":"2004","unstructured":"Trinka E, Baumgartner S, Unterberger I et al (2004) Long-term prognosis for childhood and juvenile absence epilepsy. J Neurol 251:1235\u20131241. https:\/\/doi.org\/10.1007\/s00415-004-0521-1","journal-title":"J Neurol"},{"key":"12890_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/epi.17809","volume":"65","author":"E Cerulli Irelli","year":"2024","unstructured":"Cerulli Irelli E, Gesche J, Schlabitz S et al (2024) Epilepsy with generalized tonic\u2013clonic seizures alone: electroclinical features and prognostic patterns. Epilepsia 65:84\u201394. https:\/\/doi.org\/10.1111\/epi.17809","journal-title":"Epilepsia"},{"key":"12890_CR7","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/j.yebeh.2012.06.036","volume":"28","author":"B Baykan","year":"2013","unstructured":"Baykan B, Mart\u00ednez-Ju\u00e1rez IE, Altindag EA et al (2013) Lifetime prognosis of juvenile myoclonic epilepsy. Epilepsy Behav 28:S18\u2013S24. https:\/\/doi.org\/10.1016\/j.yebeh.2012.06.036","journal-title":"Epilepsy Behav"},{"key":"12890_CR8","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S1474-4422(17)30114-X","volume":"16","author":"HJ Lamberink","year":"2017","unstructured":"Lamberink HJ, Otte WM, Geerts AT et al (2017) Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and individual participant data meta-analysis. Lancet Neurol 16:523\u2013531. https:\/\/doi.org\/10.1016\/S1474-4422(17)30114-X","journal-title":"Lancet Neurol"},{"key":"12890_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04990-6","author":"M Tombini","year":"2021","unstructured":"Tombini M, Assenza G, Quintiliani L et al (2021) Epilepsy and quality of life: what does really matter? Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-020-04990-6","journal-title":"Neurol Sci"},{"key":"12890_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2019.06.026","author":"M Tombini","year":"2019","unstructured":"Tombini M, Assenza G, Quintiliani L et al (2019) Epilepsy-associated stigma from the perspective of people with epilepsy and the community in Italy. Epilepsy Behav. https:\/\/doi.org\/10.1016\/j.yebeh.2019.06.026","journal-title":"Epilepsy Behav"},{"key":"12890_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2020.107073","author":"M Tombini","year":"2020","unstructured":"Tombini M, Assenza G, Quintiliani L et al (2020) Depressive symptoms and difficulties in emotion regulation in adult patients with epilepsy: association with quality of life and stigma. Epilepsy Behav. https:\/\/doi.org\/10.1016\/j.yebeh.2020.107073","journal-title":"Epilepsy Behav"},{"key":"12890_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2022.109029","volume":"138","author":"F Narducci","year":"2023","unstructured":"Narducci F, Lanzone J, Ricci L et al (2023) Determinants of medication adherence in people with epilepsy: a multicenter, cross-sectional survey. Epilepsy Behav 138:109029. https:\/\/doi.org\/10.1016\/j.yebeh.2022.109029","journal-title":"Epilepsy Behav"},{"key":"12890_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.18773\/austprescr.2021.005","volume":"44","author":"H Laue-Gizzi","year":"2021","unstructured":"Laue-Gizzi H (2021) Discontinuation of antiepileptic drugs in adults with epilepsy. Aust Prescr 44:53\u201356. https:\/\/doi.org\/10.18773\/austprescr.2021.005","journal-title":"Aust Prescr"},{"key":"12890_CR14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.clinph.2016.11.024","volume":"128","author":"L Tang","year":"2017","unstructured":"Tang L, Xiao Z (2017) Can electroencephalograms provide guidance for the withdrawal of antiepileptic drugs: a meta-analysis. Clin Neurophysiol 128:297\u2013302. https:\/\/doi.org\/10.1016\/j.clinph.2016.11.024","journal-title":"Clin Neurophysiol"},{"key":"12890_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2024.109718","volume":"153","author":"S Lallana","year":"2024","unstructured":"Lallana S, Fonseca E, Quintana M et al (2024) Antiseizure medication withdrawal in adult patients with idiopathic generalized epilepsy: performance of two seizure recurrence prediction models. Epilepsy Behav 153:109718. https:\/\/doi.org\/10.1016\/j.yebeh.2024.109718","journal-title":"Epilepsy Behav"},{"key":"12890_CR16","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209222","author":"E Cerulli Irelli","year":"2024","unstructured":"Cerulli Irelli E, Cocchi E, Morano A et al (2024) Predictors of seizure recurrence in women with idiopathic generalized epilepsy who switch from valproate to another medication. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000209222","journal-title":"Neurology"},{"key":"12890_CR17","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/ene.13811","volume":"26","author":"R Stevelink","year":"2019","unstructured":"Stevelink R, Koeleman BPC, Sander JW et al (2019) Refractory juvenile myoclonic epilepsy: a meta-analysis of prevalence and risk factors. Eur J Neurol 26:856\u2013864. https:\/\/doi.org\/10.1111\/ene.13811","journal-title":"Eur J Neurol"},{"key":"12890_CR18","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/epi4.12603","volume":"7","author":"T Komatsubara","year":"2022","unstructured":"Komatsubara T, Kobayashi Y, Hiraiwa A et al (2022) Recurrence rates and risk factors for seizure recurrence following antiseizure medication withdrawal in adolescent patients with genetic generalized epilepsy. Epilepsia Open 7:332\u2013343. https:\/\/doi.org\/10.1002\/epi4.12603","journal-title":"Epilepsia Open"},{"key":"12890_CR19","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.seizure.2011.03.007","volume":"20","author":"M Pavlovi\u0107","year":"2011","unstructured":"Pavlovi\u0107 M, Jovi\u0107 N, Pekmezovi\u0107 T (2011) Antiepileptic drugs withdrawal in patients with idiopathic generalized epilepsy. Seizure 20:520\u2013525. https:\/\/doi.org\/10.1016\/j.seizure.2011.03.007","journal-title":"Seizure"},{"key":"12890_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1600-0404.2005.00408.x","volume":"111","author":"D Schmidt","year":"2005","unstructured":"Schmidt D, L\u00f6scher W (2005) Uncontrolled epilepsy following discontinuation of antiepileptic drugs in seizure-free patients: a review of current clinical experience. Acta Neurol Scand 111:291\u2013300. https:\/\/doi.org\/10.1111\/j.1600-0404.2005.00408.x","journal-title":"Acta Neurol Scand"},{"key":"12890_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.braindev.2019.08.012","volume":"42","author":"ZS Karalok","year":"2020","unstructured":"Karalok ZS, Guven A, \u00d6zt\u00fcrk Z, Gurkas E (2020) Risk factors for recurrence after drug withdrawal in childhood epilepsy. Brain Dev 42:35\u201340. https:\/\/doi.org\/10.1016\/j.braindev.2019.08.012","journal-title":"Brain Dev"},{"key":"12890_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.seizure.2018.05.015","volume":"59","author":"L Healy","year":"2018","unstructured":"Healy L, Moran M, Singhal S et al (2018) Relapse after treatment withdrawal of antiepileptic drugs for juvenile absence epilepsy and juvenile myoclonic epilepsy. Seizure 59:116\u2013122. https:\/\/doi.org\/10.1016\/j.seizure.2018.05.015","journal-title":"Seizure"},{"key":"12890_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/epi.17104","volume":"63","author":"BK Kamitaki","year":"2022","unstructured":"Kamitaki BK, Janmohamed M, Kandula P et al (2022) Clinical and EEG factors associated with antiseizure medication resistance in idiopathic generalized epilepsy. Epilepsia 63:150\u2013161. https:\/\/doi.org\/10.1111\/epi.17104","journal-title":"Epilepsia"},{"issue":"19","key":"12890_CR24","doi-asserted-by":"publisher","first-page":"e1822","DOI":"10.1212\/WNL.0000000000006797","volume":"91","author":"Y Sun","year":"2018","unstructured":"Sun Y, Seneviratne U, Perucca P et al (2018) Generalized polyspike train: an EEG biomarker of drug resistant idiopathic generalized epilepsy. Neurology 91(19):e1822\u2013e1830. https:\/\/doi.org\/10.1212\/WNL.0000000000006797","journal-title":"Neurology"},{"key":"12890_CR25","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.clinph.2023.01.002","volume":"147","author":"ME Peltola","year":"2023","unstructured":"Peltola ME, Leitinger M, Halford JJ et al (2023) Routine and sleep EEG: minimum recording standards of the international federation of clinical neurophysiology and the international league against epilepsy. Clin Neurophysiol 147:108\u2013120. https:\/\/doi.org\/10.1016\/j.clinph.2023.01.002","journal-title":"Clin Neurophysiol"},{"issue":"6","key":"12890_CR26","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","volume":"51","author":"P Kwan","year":"2010","unstructured":"Kwan P, Arzimanoglou A, Berg AT et al (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia 51(6):1069\u20131077. https:\/\/doi.org\/10.1111\/j.1528-1167.2009.02397.x","journal-title":"Epilepsia"},{"key":"12890_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1046\/j.1535-7597.2003.03406.x","volume":"3","author":"AM Kanner","year":"2003","unstructured":"Kanner AM (2003) Idiopathic generalized epilepsy is not restricted to young patients. Epilepsy Curr 3:127\u2013128. https:\/\/doi.org\/10.1046\/j.1535-7597.2003.03406.x","journal-title":"Epilepsy Curr"},{"key":"12890_CR28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/epi.12305","volume":"54","author":"E Beghi","year":"2013","unstructured":"Beghi E, Giussani G, Grosso S et al (2013) Withdrawal of antiepileptic drugs: guidelines of the Italian league against epilepsy. Epilepsia 54:2\u201312. https:\/\/doi.org\/10.1111\/epi.12305","journal-title":"Epilepsia"},{"key":"12890_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1122827","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Ding H, Zhao X et al (2023) Risk factors of recurrence after drug withdrawal in children with epilepsy. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2023.1122827","journal-title":"Front Neurol"},{"key":"12890_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0300930","volume":"19","author":"C Fayad","year":"2024","unstructured":"Fayad C, Saad K, Kahwagi G-J et al (2024) A systematic review and meta-analysis of factors related to first line drugs refractoriness in patients with juvenile myoclonic epilepsy (JME). PLoS ONE 19:e0300930. https:\/\/doi.org\/10.1371\/journal.pone.0300930","journal-title":"PLoS ONE"},{"key":"12890_CR31","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1212\/WNL.47.4.912","volume":"47","author":"EC Wirrell","year":"1996","unstructured":"Wirrell EC, Camfield CS, Camfield PR et al (1996) Long-term prognosis of typical childhood absence epilepsy. Neurology 47:912\u2013918. https:\/\/doi.org\/10.1212\/WNL.47.4.912","journal-title":"Neurology"},{"key":"12890_CR32","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.braindev.2021.02.005","volume":"43","author":"N Pietrafusa","year":"2021","unstructured":"Pietrafusa N, La Neve A, de Palma L et al (2021) Juvenile myoclonic epilepsy: long-term prognosis and risk factors. Brain Dev 43:688\u2013697. https:\/\/doi.org\/10.1016\/j.braindev.2021.02.005","journal-title":"Brain Dev"},{"key":"12890_CR33","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1528-1167.2011.03344.x","volume":"53","author":"U Seneviratne","year":"2012","unstructured":"Seneviratne U, Cook M, D\u2019Souza W (2012) The electroencephalogram of idiopathic generalized epilepsy. Epilepsia 53:234\u2013248. https:\/\/doi.org\/10.1111\/j.1528-1167.2011.03344.x","journal-title":"Epilepsia"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-12890-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-12890-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-12890-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T17:42:13Z","timestamp":1742233333000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-12890-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,22]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["12890"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-12890-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,22]]},"assertion":[{"value":"23 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Davide Gusmeo Curti, Anna Bellini, Marco Cursi, Jacopo Lanzone, Fabio Minicucci, Giovanna Franca Fanelli have no relevant conflicts of interest. M. Filippi is Editor-in-Chief of the Journal of Neurology, Associate Editor of Human Brain Mapping, Neurological Sciences, and Radiology; received compensation for consulting services from Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi; speaking activities from Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA; participation in Advisory Boards for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda; scientific direction of educational events for Biogen, Merck, Roche, Celgene, Bristol-Myers Squibb, Lilly, Novartis, Sanofi-Genzyme; he receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla. F. Agosta is Associate Editor of NeuroImage: clinical, has received speaker honoraria from Biogen Idec, Italfarmaco, Roche, Zambon and Eli Lilly, and receives or has received research supports from the Italian Ministry of Health, the Italian Ministry of University and Research, AriSLA (Fondazione Italiana di Ricerca per la SLA), the European Research Council, the EU Joint Programme\u2013Neurodegenerative Disease Research (JPND), and Foundation Research on Alzheimer Disease (France).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"A written informed consent was obtained from all subjects according to the Declaration of Helsinki before enrolment in the study. The study protocol was approved by the Ethics Committee of IRCCS Ospedale San Raffaele.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors did not use any use generative artificial intelligence (AI) and AI-assisted technologies in the writing process.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI"}}],"article-number":"218"}}